Skip to main content
    T

    Tilray Inc (TLRY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $2.34
    -0.09 (-3.70%)

    Market Cap: $359.12M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Tilray Inc (TLRY) Financials: Revenue, Profit and Cash Flow

    Updated Oct 8, 2026. Financial statements from company filings, amounts in US dollars.

    Tilray reported revenue of $915.45M for the fiscal year ended May 31, 2026, up 11.5% from the year before. That year, net income was -$122.57M with a net margin of -13.4%, operating cash flow was -$69.14M and free cash flow was -$102.13M. The quarter ended Aug 31, 2026 had revenue of $257.15M and net income of -$43.14M.

    Revenue and Margins

    The operating margin was -6.9% in the fiscal year ended May 2026. Over the 9 years to May 2026, revenue grew from $15.17M, a compound annual rate of 57.7%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    May 2026$915.45M+11.5%28.4%-6.9%-13.4%
    May 2025$821.31M+4.1%29.3%-277.9%-266.3%
    May 2024$788.94M+25.8%28.3%-22.1%-31.1%
    May 2023$627.12M-0.2%23.4%-218.4%-231.6%
    May 2022$628.37M+22.5%18.6%-37.1%-75.9%
    May 2021$513.09M+74.0%24.0%-25.8%-71.6%
    May 2020$294.96M+583.9%23.7%-25.7%-25.3%
    May 2019$43.13M+110.0%74.7%-85.0%-157.0%
    May 2018$20.54M+35.4%119.2%-36.5%-38.0%
    May 2017$15.17MN/A84.6%-6.8%20.5%
    Annual, fiscal years ended May 2017 to May 2026

    Income Statement

    In the fiscal year ended May 2026, the net loss narrowed from the year before. In the quarter ended Aug 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemMay 2026May 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017
    Revenue$915.45M$821.31M$788.94M$627.12M$628.37M$513.09M$294.96M$43.13M$20.54M$15.17M
    Cost of revenue$655.01M$580.74M$565.59M$480.16M$511.56M$389.90M$225.06M$100.53M-$2.38M$2.33M
    Gross profit$260.44M$240.57M$223.35M$146.96M$116.82M$123.18M$69.90M$32.21M$24.49M$12.84M
    Research and development$361.00K$284.00K$635.00K$682.00K$1.52M$830.00K$1.39M$778.84K$293.44K$365.21K
    Operating income-$63.03M-$2.28B-$174.75M-$1.37B-$233.27M-$132.17M-$75.69M-$36.66M-$7.50M-$1.03M
    Net income-$122.57M-$2.19B-$244.98M-$1.45B-$476.80M-$367.42M-$74.62M-$67.72M-$7.81M$3.12M
    EBITDA$9.45M-$2.13B-$72.84M-$1.27BN/AN/A-$44.94M-$20.32M-$5.64M$4.94M
    Fiscal years ended May 2017 to May 2026

    Quarterly

    Line itemAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Revenue$257.15M$281.71M$206.73M$217.51M$209.50M$224.53M$185.78M$210.95M$200.04M$229.88M$188.34M$193.77M
    Gross profit$77.51M$84.33M$54.95M$57.50M$57.47M$67.63M$52.01M$61.22M$59.71M$82.35M$49.40M$47.41M
    Operating income-$24.05M-$4.49M-$26.39M-$22.28M$2.09M-$1.44B-$759.93M-$42.22M-$36.57M-$16.53M-$82.10M-$41.76M
    Net income-$43.14M-$49.57M-$26.57M-$44.93M-$322.00K-$1.27B-$789.44M-$85.34M-$39.16M-$31.75M-$92.70M-$49.01M
    Last 12 quarters

    Balance Sheet

    As of May 2026, total debt of $240.25M exceeded cash and equivalents by $14.27M.

    Annual

    Line itemMay 2026May 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017
    Total assets$2.33B$2.07B$4.22B$4.31B$5.45B$6.03B$868.89M$661.89M$53.09M$44.91M
    Current assets$792.13M$674.85M$659.95M$757.13M$803.50M$883.61M$251.10M$558.71M$12.18M$16.38M
    Cash and equivalents$225.98M$217.23M$222.36M$202.38M$415.91M$488.47M$93.83M$491.13M$2.28M$10.17M
    Total liabilities$733.14M$614.55M$868.73M$1.05B$1.01B$1.56B$592.35M$462.67M$57.85M$41.49M
    Short-term debt$40.29M$28.31M$37.94M$219.65M$92.65M$49.60M$3.85M$473.74K$41.86M$27.19M
    Long-term debt$199.95M$234.92M$287.94M$357.93M$519.83M$835.11M$290.43MN/AN/AN/A
    Shareholder equity$1.61B$1.48B$3.35B$3.25B$4.40B$4.46B$276.54M$199.23M-$4.76M$3.42M
    Fiscal years ended May 2017 to May 2026

    Quarterly

    Line itemAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Total assets$2.33B$2.33B$2.07B$2.10B$2.08B$2.07B$4.92B$4.19B$4.26B$4.22B$4.21B$4.33B
    Total liabilities$721.28M$733.14M$549.12M$552.09M$561.99M$614.55M$1.01B$738.15M$778.45M$868.73M$869.82M$937.20M
    Cash and equivalents$214.96M$225.98M$204.62M$246.70M$264.83M$217.23M$288.82M$189.70M$205.19M$222.36M$146.25M$144.95M
    Shareholder equity$1.62B$1.61B$1.56B$1.58B$1.54B$1.48B$3.94B$3.47B$3.48B$3.35B$3.36B$3.37B
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended May 2026.

    Annual

    Line itemMay 2026May 2025May 2024May 2023May 2022May 2021May 2020May 2019May 2018May 2017
    Operating cash flow-$69.14M-$94.60M-$30.91M$7.91M-$177.26M-$53.99M-$250.16M-$46.62M-$5.89M-$4.48M
    Capital expenditures$32.99M$32.92M$29.25M$20.80M$34.06M$46.94M$71.48M$50.60M$10.71M$659.26K
    Free cash flow-$102.13M-$127.52M-$60.15M-$12.89M-$211.33M-$100.93M-$321.65M-$97.21M-$16.60M-$5.14M
    Dividends paidN/A$1.54MN/A$81.44M$7.48BN/AN/AN/AN/AN/A
    Investing cash flow-$55.80M-$46.72M$128.35M-$285.11M-$21.53M$55.67M-$245.43M-$99.41M-$11.60MN/A
    Financing cash flow$130.99M$133.51M-$75.19M$70.16M$128.20M$150.09M$111.19M$636.02M$12.01M$14.75M
    Fiscal years ended May 2017 to May 2026

    Quarterly

    Line itemAug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023
    Operating cash flow-$16.54M-$37.47M-$21.94M-$8.54M-$1.34M-$12.81M-$5.76M-$40.72M-$35.31M$30.71M-$15.36M-$30.41M
    Capital expenditures$11.01M$10.19M$3.62M$9.70M$9.52M$6.33M$14.41M$5.44M$6.74M$9.71M$9.53M$5.86M
    Free cash flow-$27.55M-$47.66M-$25.56M-$18.23M-$10.86M-$19.14M-$20.18M-$46.16M-$42.04M$21.00M-$24.89M-$36.27M
    Last 12 quarters

    Frequently Asked Questions About TLRY

    What is Tilray's annual revenue?

    Tilray reported revenue of $915.45M for the fiscal year ended May 31, 2026.

    How fast is Tilray's revenue growing?

    Revenue was up 11.5% for the fiscal year ended May 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 13.4%.

    Is Tilray profitable?

    No. Tilray reported net income of -$122.57M for the fiscal year ended May 31, 2026, with a net margin of -13.4%.

    How much free cash flow does TLRY generate?

    For the fiscal year ended May 31, 2026, operating cash flow of -$69.14M minus capital expenditures of $32.99M produced free cash flow of -$102.13M.

    How much debt does Tilray have?

    The balance sheet dated May 31, 2026 reported long-term debt of $199.95M, short-term debt of $40.29M and cash and equivalents of $225.98M.